BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15132903)

  • 1. [Study of HLA molecules and its associated genes expression in human ovarian cancer cells].
    Ge HL; Zhang XR; Wang Y; Ma AL; Zhang HZ; Wang SJ; Zhou GY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):41-4. PubMed ID: 15132903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer.
    Fellerhoff B; Gu S; Laumbacher B; Nerlich AG; Weiss EH; Glas J; Kopp R; Johnson JP; Wank R
    Cancer Res; 2011 Dec; 71(23):7145-54. PubMed ID: 22037870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HLA class II-associated peptide transporter and proteasome genes in human placentas and trophoblast cell lines.
    Roby KF; Fei K; Yang Y; Hunt JS
    Immunology; 1994 Nov; 83(3):444-8. PubMed ID: 7835969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of CIITA Gene in five human cell lines and its significance].
    Zuo WL; Song YP; Guo R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1158-61. PubMed ID: 18928617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
    Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K
    Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective modulation of MHC class II chaperons by a novel IFN-γ-inducible class II transactivator variant in lung adenocarcinoma A549 cells.
    Chiu BL; Li CH; Chang CC
    Biochem Biophys Res Commun; 2013 Oct; 440(1):190-5. PubMed ID: 24055710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
    Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
    Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma.
    Seliger B; Hammers S; Höhne A; Zeidler R; Knuth A; Gerharz CD; Huber C
    Clin Cancer Res; 1997 Apr; 3(4):573-8. PubMed ID: 9815722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene required for normal MHC class II expression and function is localized to approximately 45 kb of DNA in the class II region of the MHC.
    Ceman S; Petersen JW; Pinet V; DeMars R
    J Immunol; 1994 Mar; 152(6):2865-73. PubMed ID: 8144887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
    Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
    Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.